These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 19276541

  • 1. Neuron-glia interactions as therapeutic targets in neurodegeneration.
    Salmina AB.
    J Alzheimers Dis; 2009; 16(3):485-502. PubMed ID: 19276541
    [Abstract] [Full Text] [Related]

  • 2. Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control.
    Salmina AB, Inzhutova AI, Malinovskaya NA, Petrova MM.
    J Alzheimers Dis; 2010; 22(1):17-36. PubMed ID: 20847414
    [Abstract] [Full Text] [Related]

  • 3. Are paradoxical cell cycle activities in neurons and glia related to the metabolic theory of Alzheimer's disease?
    Erol A.
    J Alzheimers Dis; 2010; 19(1):129-35. PubMed ID: 20061632
    [Abstract] [Full Text] [Related]

  • 4. Glial reaction in aging and Alzheimer's disease.
    Unger JW.
    Microsc Res Tech; 1998 Oct 01; 43(1):24-8. PubMed ID: 9829455
    [Abstract] [Full Text] [Related]

  • 5. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F, Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B.
    Neuroscience; 2006 Oct 01; 138(3):869-78. PubMed ID: 16337092
    [Abstract] [Full Text] [Related]

  • 6. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
    Koning N, Swaab DF, Hoek RM, Huitinga I.
    J Neuropathol Exp Neurol; 2009 Feb 01; 68(2):159-67. PubMed ID: 19151626
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
    Wirths O, Breyhan H, Marcello A, Cotel MC, Brück W, Bayer TA.
    Neurobiol Aging; 2010 May 01; 31(5):747-57. PubMed ID: 18657882
    [Abstract] [Full Text] [Related]

  • 8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 01; 104(6):583-91. PubMed ID: 12410379
    [Abstract] [Full Text] [Related]

  • 9. Neuron-glia interrelations.
    Vernadakis A.
    Int Rev Neurobiol; 1988 Dec 01; 30():149-224. PubMed ID: 3061968
    [Abstract] [Full Text] [Related]

  • 10. Astrocytic dysfunction: insights on the role in neurodegeneration.
    Rossi D, Volterra A.
    Brain Res Bull; 2009 Oct 28; 80(4-5):224-32. PubMed ID: 19631259
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroglia in neurodegeneration.
    Heneka MT, Rodríguez JJ, Verkhratsky A.
    Brain Res Rev; 2010 May 28; 63(1-2):189-211. PubMed ID: 19944719
    [Abstract] [Full Text] [Related]

  • 13. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism.
    Ke ZJ, Gibson GE.
    Neurochem Int; 2004 May 28; 45(2-3):361-9. PubMed ID: 15145550
    [Abstract] [Full Text] [Related]

  • 14. Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38.
    Xie Z, Smith CJ, Van Eldik LJ.
    Glia; 2004 Jan 15; 45(2):170-9. PubMed ID: 14730710
    [Abstract] [Full Text] [Related]

  • 15. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
    Liu Y, Qin L, Li G, Zhang W, An L, Liu B, Hong JS.
    J Pharmacol Exp Ther; 2003 Apr 15; 305(1):212-8. PubMed ID: 12649371
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
    Tian YY, An LJ, Jiang L, Duan YL, Chen J, Jiang B.
    Life Sci; 2006 Dec 23; 80(3):193-9. PubMed ID: 17049947
    [Abstract] [Full Text] [Related]

  • 18. Synaptic degeneration in Alzheimer's disease.
    Arendt T.
    Acta Neuropathol; 2009 Jul 23; 118(1):167-79. PubMed ID: 19390859
    [Abstract] [Full Text] [Related]

  • 19. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
    Chiarini A, Dal Pra I, Whitfield JF, Armato U.
    Ital J Anat Embryol; 2006 Jul 23; 111(4):221-46. PubMed ID: 17385278
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.